Leadership
VAST Scientific principals and staff are the basis of our business.
Confident and enthusiastic leadership are the cornerstones to collaborative
success with our customers and partners. Our professional staff
consists of Ph.D. level scientists with expertise in biology, biochemistry,
bioinformatics, other related fields, and of high level computer
scientists and software engineers with extensive knowledge and
experience in building and optimizing applications for life sciences.
VAST Scientific Principals
Athanas’ unique application of the intersection of his skills
and experience as a scientist, data analyst, software architect,
developer, IT architect, and project & team manager has provided
measurable benefit to many leading life science companies. At VAST,
Athanas builds and extends his success as founding partner and
President of The BioTeam at building a highly reputable, responsive,
and professional team of industry experts. Athanas has an extended
history of bringing successful software products to market including
BioTeam’s iNquiry, Blackstone's SmartCache, and ThermoFisher
Scientific’s SIEVE. For Prior to the BioTeam, Athanas was
Director of Scientific Consulting at Blackstone Computing, Athanas
led a highly reputable team of scientists and developers focused
upon enabling large-scale vendor neutral scientific computing solutions.
He is the inventor (patent pending) of unique scalable data balancing
algorithms that have provided core IP to Blackstone software products.
As a Bioinformaticist at Cereon Genomics he collaborated in the
transcriptional profiling team as well as created software infrastructures
for high-throughput analysis including a scalable workflow engine
based upon mobile agent technologies. Previous to Cereon, Athanas
was a Research Scientist at Cornell University’s Wilson Synchrotron
Laboratory exploring four-quark bound states produced in photon-photon
interactions. At Cornell, he was Co-Architect of the Nile Project,
a National Science Foundation project addressing large-scale databases
and distributed computing in experimental elementary particle physics.
Athanas received his Doctorate in Physics at the Mellon College
of Science at Carnegie Mellon in Pittsburgh.
As a computational scientist and entrepreneur for 20 years Griffin
has made important contributions in a diverse set of disciplines.
His novel stock trading algorithm based on the quantification of
information flow is currently being used by a large investment
management company on Wall St. He recently designed and developed
a scalable mass spectrometry peak detection platform for a Harvard
Medical School laboratory. As co-founder of Xpogen, Inc., he conceptualized
and managed the development of a web-based research platform for
functional genomics discovery based on a graph theoretic approach
to analyzing gene expression data. For his doctoral research Griffin
developed a supercomputer-based platform for predicting the maneuvering
characteristics of near-surface submarines. Using high performance
software he developed while working at a U.S. Navy research laboratory,
Griffin redesigned an appendage with dramatically improved performance
for a fleet of destroyers. Griffin has a doctorate in computational
fluid dynamics from the Massachusetts Institute of Technology.
VAST Scientific Advisory Board
Michael Fahy
For over 20 years Fahy has served in various roles in sales,
sales management and operations management within the high
technology product and professional services sector. Within the last
7 years, Fahy has held various senior executive positions for drug
discovery informatics and computational infrastructure firms
including Xpogen, Inc. and The Blackstone Technology Group, Inc.
Prior to that Fahy served 10 years at Uniform Information Services,
Inc. where, as Vice President of Sales, he helped to transform the
company's product and sales strategy away from traditional models of
delivery over to Internet-based solutions and services. Fahy
is a graduate of The University of Buffalo with a B.S in Mechanical
Engineering.
Gaƫl McGill, Ph.D.
McGill is currently CEO of Digizyme, Inc. a firm dedicated to the
visualization and communication of science through advanced
technology applications. Gael is also a visiting lecturer at Harvard
Medical School. McGill has served as a scientific and
communications consultant for the Boston Scientific Corporation and
remains a Technical Review Board member there. He has also served as
Director of Product Development & New Technologies at Xpogen, Inc.,
an enterprise bioinformatics software company, and a director of the
Harvard Biotechnology Club where he has organized seminar series on
issues of science and entrepreneurship in biotechnology. After
working at Dupont-Merck Pharmaceuticals and INSERM/Cochin Hospital
in Paris, he completed his PhD at Harvard Medical School in the
Division of Medical Sciences (Biochemistry & Molecular
Pharmacology). His research on the mechanisms of tumor cell
death/apoptosis was supported by the prestigious Howard Hughes
Medical Institute and Sandoz Pharmaceuticals fellowships, and
resulted in numerous peer-reviewed publications (including the cover
of Cell, and highlighted by BBC media & other news organizations).
McGill received his B.A. summa cum laude in Biology, Music, and Art
History from Swarthmore College.
[ back to top ]
|
|